The “CYLD Gene Cylindromatosis Familial Genetic Test” is a specialized diagnostic procedure aimed at detecting mutations in the CYLD gene, which is known to cause cylindromatosis. Cylindromatosis is a rare genetic condition characterized by the development of multiple benign tumors, primarily affecting the skin. These tumors, known as cylindromas, typically arise in areas such as the scalp, face, and neck. The condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.

This genetic test is crucial for families with a history of cylindromatosis, as it helps in identifying individuals who carry the genetic mutation. Early identification of carriers allows for timely surveillance and management of the condition, potentially preventing or minimizing the development of skin tumors. Moreover, the test can provide essential information for affected families regarding the risk of passing the condition to future generations.

Conducted at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The laboratory then analyzes the CYLD gene for specific mutations known to cause cylindromatosis. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately.

Given the rarity of cylindromatosis and the importance of genetic counseling, individuals considering this test are often advised to consult with a genetic counselor or a specialist in genetic diseases. This professional guidance ensures that individuals and families fully understand the implications of the test results and the condition itself.